...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: AHA late breaking abstract
2
Nov 10, 2019 12:59PM

Yes, this is correct. The trial will have been accepted for presentation on the basis of its design, conduct, and importance. It was well designed (approved by the FDA); it was well conducted; and the results are very important, clinically and scientifically, whether positive or negative. 

1
Nov 11, 2019 07:49AM
3
Nov 11, 2019 09:15AM
10
Nov 11, 2019 09:36AM
5
Nov 11, 2019 09:54AM
3
Nov 11, 2019 10:52AM
4
Nov 11, 2019 02:26PM
Share
New Message
Please login to post a reply